CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 26 enrolled
Drug / intervention
Probiotics in SIBO +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02204891
NCT02204891N/ACompleted
CompareCT.gov

A Clinical Study of the Efficacy of a Formulation of Four Probiotics in Patients With Syndrome of Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome

University of Athens·interventional·Posted Jul 31, 2014·Updated Mar 20, 2017

In Brief

A clinical study evaluating Probiotics in SIBO and Probiotics for Irritable Bowel Syndrome. Completed, enrolled 26 participants across 1 site.

Detailed Summary

The aim of the present study is to demonstrate the effect of a mixture of four species of probiotics (Saccharomyces boulardii, Bifidobacterium lactis BB-12, Lactobacillus acidophilus LA-5 and Lactobacillus plantarum) in patients with symptomatic irritable bowel syndrome (IBS) who have culture verified syndrome of intestinal bacterial overgrowth (SIBO) and those who do not have. This will provide direct evidence for the role of probiotics in treating part of the pathogenesis of IBS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIrritable Bowel Syndrome
CountriesGreece
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 31, 2014
Enrollment StartSep 1, 2014
Primary CompletionJun 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.9 years ago

Interventions

Probiotics in SIBOdietary

Mixture of the four probiotics in one capsule. One capsule twice daily for 30 days

Probioticsdietary

One capsule twice daily for 30 days